Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancer.

Carlson, Aaron M

Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancer. [electronic resource] - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Oct 2013 - 1730-5 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1538-7755

10.1158/1055-9965.EPI-12-1368 doi


Adult
Aged
Aged, 80 and over
Biomarkers, Tumor--blood
Carcinoma, Ovarian Epithelial
Cohort Studies
Female
Humans
Intercellular Signaling Peptides and Proteins--blood
Leukocytes--metabolism
Middle Aged
Neoplasms, Glandular and Epithelial--blood
Ovarian Neoplasms--blood
Prognosis
Progranulins
Protease Inhibitors--blood
Secretory Leukocyte Peptidase Inhibitor--blood
Survival Analysis